PortfoliosLab logoPortfoliosLab logo
XPH vs. XLE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XPH vs. XLE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Pharmaceuticals ETF (XPH) and State Street Energy Select Sector SPDR ETF (XLE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XPH achieves a 0.66% return, which is significantly lower than XLE's 32.17% return. Over the past 10 years, XPH has underperformed XLE with an annualized return of 3.44%, while XLE has yielded a comparatively higher 10.22% annualized return.


XPH

1D
1.10%
1M
-4.74%
YTD
0.66%
6M
4.44%
1Y
37.98%
3Y*
13.07%
5Y*
3.50%
10Y*
3.44%

XLE

1D
1.29%
1M
-1.14%
YTD
32.17%
6M
29.80%
1Y
45.00%
3Y*
17.46%
5Y*
20.44%
10Y*
10.22%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XPH vs. XLE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
XPH
SPDR S&P Pharmaceuticals ETF
0.66%31.60%4.94%2.97%-9.83%-10.54%14.68%25.61%-15.32%12.05%
XLE
State Street Energy Select Sector SPDR ETF
32.17%7.88%5.56%-0.63%64.32%53.28%-32.67%11.74%-18.22%-0.89%

Correlation

The correlation between XPH and XLE is -0.12, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (10Y)
Calculated over the trailing 10-year period

0.34

Correlation (All Time)
Calculated using the full available price history since Jun 23, 2006

0.40

The correlation between XPH and XLE shifts across timeframes, from -0.12 (1 year) to 0.40 (all time), reflecting how their relationship changes across market environments.

XPH vs. XLE - Sectors Allocation Comparison


Sectors
XPH
XLE

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

100.0%

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

XPH
100.0%
XLE

-

Basic Materials

XPH

-

XLE

-

Communication Services

XPH

-

XLE

-

Consumer Cyclical

XPH

-

XLE

-

Consumer Defensive

XPH

-

XLE

-

Energy

XPH

-

XLE
100.0%

Financial Services

XPH

-

XLE

-

Industrials

XPH

-

XLE

-

Real Estate

XPH

-

XLE

-

Technology

XPH

-

XLE

-

Utilities

XPH

-

XLE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XPH vs. XLE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XPH
XPH Risk / Return Rank: 5555
Overall Rank
XPH Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
XPH Sortino Ratio Rank: 5151
Sortino Ratio Rank
XPH Omega Ratio Rank: 4646
Omega Ratio Rank
XPH Calmar Ratio Rank: 6464
Calmar Ratio Rank
XPH Martin Ratio Rank: 6363
Martin Ratio Rank

XLE
XLE Risk / Return Rank: 6363
Overall Rank
XLE Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
XLE Sortino Ratio Rank: 5959
Sortino Ratio Rank
XLE Omega Ratio Rank: 5656
Omega Ratio Rank
XLE Calmar Ratio Rank: 7373
Calmar Ratio Rank
XLE Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XPH vs. XLE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and State Street Energy Select Sector SPDR ETF (XLE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XPHXLEDifference
Sharpe ratioReturn per unit of total volatility

-0.43

Sortino ratioReturn per unit of downside risk

-0.33

Omega ratioGain probability vs. loss probability

1.30

1.35

-0.06

Calmar ratioReturn relative to maximum drawdown

3.19

3.75

-0.56

Martin ratioReturn relative to average drawdown

11.37

10.92

+0.45

XPH vs. XLE - Sharpe Ratio Comparison

The current XPH Sharpe Ratio is 1.77, which is comparable to the XLE Sharpe Ratio of 2.21. The chart below compares the historical Sharpe Ratios of XPH and XLE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


XPHXLEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.77

2.21

-0.43

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.17

0.79

-0.62

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.16

0.35

-0.19

Sharpe Ratio (All Time)

Calculated using the full available price history

0.38

0.31

+0.07

Drawdowns

XPH vs. XLE - Drawdown Comparison

The maximum XPH drawdown since its inception was -48.03%, smaller than the maximum XLE drawdown of -71.26%. Use the drawdown chart below to compare losses from any high point for XPH and XLE.


Loading charts...

Drawdown Indicators


XPHXLEDifference

Max Drawdown

Largest peak-to-trough decline

-48.03%

-71.26%

+23.23%

Max Drawdown (1Y)

Largest decline over 1 year

-11.97%

-12.05%

+0.08%

Max Drawdown (3Y)

Largest decline over 3 years

-23.57%

-20.14%

-3.43%

Max Drawdown (5Y)

Largest decline over 5 years

-31.63%

-26.04%

-5.59%

Max Drawdown (10Y)

Largest decline over 10 years

-35.97%

-66.81%

+30.84%

Current Drawdown

Current decline from peak

-7.22%

-6.15%

-1.07%

Average Drawdown

Average peak-to-trough decline

-17.25%

-17.98%

+0.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.35%

4.14%

-0.79%

Volatility

XPH vs. XLE - Volatility Comparison

The current volatility for SPDR S&P Pharmaceuticals ETF (XPH) is 7.03%, while State Street Energy Select Sector SPDR ETF (XLE) has a volatility of 8.25%. This indicates that XPH experiences smaller price fluctuations and is considered to be less risky than XLE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XPHXLEDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.03%

8.25%

-1.22%

Volatility (6M)

Calculated over the trailing 6-month period

16.77%

16.58%

+0.19%

Volatility (1Y)

Calculated over the trailing 1-year period

21.52%

20.53%

+0.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.84%

26.02%

-5.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.10%

29.59%

-7.49%

XPH vs. XLE - Expense Ratio Comparison

XPH has a 0.35% expense ratio, which is higher than XLE's 0.08% expense ratio.


Dividends

XPH vs. XLE - Dividend Comparison

XPH's dividend yield for the trailing twelve months is around 0.66%, less than XLE's 2.54% yield.


PositionTTM20252024202320222021202020192018201720162015
XLE
State Street Energy Select Sector SPDR ETF
2.54%3.28%3.36%3.55%3.68%4.21%5.62%6.72%3.54%3.03%2.26%3.39%
XPH
SPDR S&P Pharmaceuticals ETF
0.66%0.83%1.58%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%

Frequently Asked Questions


XPH and XLE have a correlation of -0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XLE has higher volatility (8.25%) compared to XPH (7.03%). In terms of maximum drawdown, XPH dropped -48.03% vs XLE's -71.26%.

On 10-year performance, XLE leads with 10.22% vs 3.44% for XPH. On fees, XLE is cheaper at 0.08% per year. On volatility, XPH has been the lower-risk option at 7.03%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, XLE has performed better with a 10.22% return vs 3.44%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XLE is cheaper with a 0.08% expense ratio, compared with 0.35% for XPH.

XLE has the higher dividend yield at 2.54%, compared with 0.66% for XPH.

XPH is categorized as Health & Biotech Equities, while XLE is Energy Equities. XPH tracks S&P Pharmaceuticals Select Industry Index, while XLE tracks Energy Select Sector Index. Their fees differ too: 0.35% for XPH and 0.08% for XLE.

XLE currently has the higher Sharpe Ratio (2.21 vs 1.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XPH and XLE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer